NYBA Annual Meeting: The Wrap Up
Written on May 4, 2012
The New York Biotech Association Annual Meeting last Wednesday and Thursday was a success, showcasing 15 emerging companies as well as two dozen panels over the two-day span. Held in the Marriott Marquis Hotel, a staple of Times Square, the 21st annual conference was well attended with over 800 investors,...
MPR Associates Discuss Project Management and Execution in Medical Device Development
Written on May 4, 2012
As part of a OneMedRadio series, MPR Associates takes us through the process of medical device development. Below, Ralph Paul and Eric Claude discuss the importance of project management and execution.
Click below to hear full audio interview and see transcript that...
Emmy-winning Daytime Series, THE DOCTORS, To Reveal Results of a New Surgical Procedure for Parkinson’s Disease.
Written on May 1, 2012
Each year, approximately 60,000 Americans are diagnosed with Parkinson’s disease, while an estimated seven to 10 million people worldwide are living with the degenerative disorder. On May 2, the Emmy-winning syndicated daytime series, THE DOCTORS, will reveal the stunning results of a new surgical...
CIN Special Report: Part II, Treatments Ready to Eradicate Pre-Cervical Cancer
Written on May 1, 2012
In response to some recent successes by several companies operating in the cervical cancer space, we are issuing a two-part special report exploring pre-cervical cancer and CIN. Part II of the report identifies several disruptive technologies that may overcome the challenges of mainstream treatments. After...
This Week In Diagnostics
Written on Apr 30, 2012
Horizon Discovery and H3 Biomedicine collaborate on personalized medicines
Horizon Discovery and H3 Biomedicine say they have entered into a collaboration agreement to identify and validate a panel of novel cancer drug targets. They plan to perform target-validation experiments identifying critical cancer...
CIN Special Report: Part I, Can a Dangerous Pre-Cancer Threat Be Tamed?
Written on Apr 30, 2012
In response to some recent successes by several companies operating in the cervical cancer space, we are issuing a two-part special report exploring pre-cervical cancer and CIN. Part I of this report is a survey of the conditions: a description of how CIN and similar diseases affect the body, the domestic...
